Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …

NAD+, as an emerging regulator of immune responses during viral infections, may be a
promising therapeutic target for coronavirus disease 2019 (COVID-19). In this Opinion, we …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) dysregulates antiviral
signaling, immune response, and cell metabolism in human body. Viral genome and …

Viral infections alter host cell metabolism and homeostasis; however, the mechanisms that
regulate these processes have only begun to be elucidated. We report here that Zika virus …

While nucleic acid-targeting effectors are known to be central to biological conflicts and anti-
selfish element immunity, recent findings have revealed immune effectors that target their …

NMN is the direct precursor of nicotinamide adenine dinucleotide (NAD+) and is considered
as a key factor for increasing NAD+ levels and mitochondrial activity in cells. In this study …

Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), long COVID (LC) and
post-COVID-19 vaccine syndrome show similarities in their pathophysiology and clinical …

The immune repertoires of mollusks beyond commercially important organisms such as the
pacific oyster Crassostrea gigas or vectors for human pathogens like the bloodfluke planorb …

NAD+ and ADP-ribose (ADPr)-containing molecules are at the interface of virus–host
conflicts across life encompassing RNA processing, restriction, lysogeny/dormancy and …

Lower respiratory tract infections caused by Streptococcus pneumoniae (Spn) are a leading
cause of death globally. Here we investigate the bronchial epithelial cellular response to …